CVS HEALTH CORP
CVSNYSETrading Snapshot
- Day Range
- $85.62 β $87.55
- 52-Week Range
- $69.51 β $110.68
- Volume
- $5.02B
- Avg Volume
- $5.90B
- Shares Outstanding
- 1.28B
- Next Earnings
- Dec 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $402.07B
- Last Q Revenue
- $106.10B
- P/E Ratio
- 23.3
- P/S Ratio
- 0.3x
- EPS (TTM)
- $3.84
- Dividend Yield
- 2.98%
- Dilution (1yr)
- +1.3%
Why Investors Own CVS
- βHigh-growth profile β revenue up +39.7% YoY with expanding US Equity exposure.
- βHealthy economics β 29% gross margin and 21% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CVS HEALTH CORP
CVSAbout CVS HEALTH CORP
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
CVS HEALTH CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CVS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CVS HEALTH CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.